Adult black fly with Onchocerca volvulus emerging from the insect’s antenna Photo: United States Department of Agriculture
Onchoceriasis – also known as river blindness – is the world’s second leading infectious cause of blindness. The disease is caused by the nematode,
Onchocerca volvulus, and is transmitted to humans through the bite of a blackfly. Once inside the body, the female worm produces thousands of larval worms (microfilariae) which migrate to the skin and eyes. When the microfilariae die, they cause intense itching and a strong immune response that can destroy nearby tissue, leading eventually to blindness and disfiguring skin lesions. Control programmes have involved the use of larvicides to reduce blackfly populations and the use of ivermectin to treat infected people and limit the spread of disease. Ivermectin is most effective against the larval stage of the worm and is believed to kill the parasites by activating glutamate-gated chloride channels which are specific to invertebrates.
Closantel
A team led by researchers at the
Scripps Institute has now focused on a new way to kill the parasite. The protective outer cuticle of the worms is made of chitin and two classes of enzymes – chitin synthases and chitinases – are known to be critical for chitin formation and remodelling. One chitinase, OvCHT1, is expressed only in the infective third-stage larvae and is believed to be involved in development and host transmission. The team screened a small library of compounds for activity against OvCHT1 and found that closantel was able to inhibit the enzyme. When closantel was tested on cultured third-stage larvae, the compound prevented the larvae from moulting and developing into adult worms. Since the mechanism of action of closantel is completely different to that of ivermectin, it – or other chitinase inhibitors – could potentially be used to treat ivermectin-resistant worms. Closantel is a broad-spectrum anti-parasitic agent currently used in some countries in veterinary medicine.
The study is published in the Proceedings of the National Academy of Sciences.
Related posts:
- New ‘Broad-Spectrum’ Antiviral Although a variety of broad-spectrum antibiotics have been developed, broad-spectrum antiviral agents have proved more difficult to identify. Effective treatments...
- Drug Discovery with Zebrafish Scientists at Vanderbilt University have previously used zebrafish embryos to identify compounds that interfere with signalling pathways involved in early...
- Locking out or Locking in – It’s Not the Same Key for Malaria Plasmodium parasites, responsible for malaria in humans, have a complex lifecycle that is dependent on mosquito and human hosts. In...
- How Small Molecule Restores Aldehyde Dehydrogenase Function The lower alcohol tolerance of some Asian groups compared with people of European descent is caused, in part, by a...
- Serotonin Synthesis Inhibitor Could Treat Osteoporosis In 2008, researchers led by a team at Columbia University showed that, by turning on or off production of serotonin...
Related posts brought to you by Yet Another Related Posts Plugin.
Email This Post
This entry was posted on Friday, February 12th, 2010 at 8:44 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Entries (RSS)